Hospitals

Community, Critical Access Hospitals Select Oracle Health CommunityWorks to Enhance Clinical and Financial Operations

New integrations extend the value of CommunityWorks with AI, data exchange, and patient accounting capabilities AUSTIN, Texas, Sept. 24, 2024…

1 year ago

Inspira™ Launches INSPIRA™ ART100 at the World’s Largest Extracorporeal Life Support Conference

RA'ANANA, Israel, Sept. 24, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW), ("Inspira Technologies", "Inspira", or the…

1 year ago

New Research from Waystar and Modern Healthcare Reveals AI’s Transformative Impact on Healthcare Payments

Leading health systems and providers experience increased productivity, revenue, and satisfaction with AI adoption 75% report positive ROI from AI…

1 year ago

Hackensack Meridian Health Network Deploys ZeroEyes’ AI Gun Detection and Intelligent Situational Awareness Platform

New Jersey Hospital System Integrates Proactive Security Technology to Mitigate Gun-Related Violence PHILADELPHIA, Sept. 24, 2024 /PRNewswire/ -- ZeroEyes, the…

1 year ago

InteliChart Enters New Agreement with Office Practicum to Amplify Patient Engagement for Pediatric Practices

Enhanced benefits and award-winning patient engagement solutions for pediatric practices. CHARLOTTE, N.C., Sept. 24, 2024 /PRNewswire/ -- InteliChart, an award-winning…

1 year ago

Get Well Earns FedRAMP Authorized Designation

Get Well's cross-continuum digital patient engagement platform can now be accessed through AWS GovCloud and cloud services by federal organizations to…

1 year ago

Senzime Secures New Contract With Leading US Healthcare System

UPPSALA, SWEDEN / ACCESSWIRE / September 24, 2024 / Senzime AB (STO:SEZI)(OTCQX:SNZZF) today announced that it has secured an initial…

1 year ago

TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol Change to “SCNX”

TRxADE Health, Inc. today announced that it changed its name and ticker symbol to “Scienture Holdings, Inc.” and “SCNX”, respectively,…

1 year ago

Oxford-Harrington Rare Disease Centre to Host Symposium on Pioneering Research and Innovation in Rare Disease Treatments

OXFORD, UK and CLEVELAND, Ohio, US, 24th September 2024 – The Oxford-Harrington Rare Disease Centre (‘OHC’), a partnership between the…

1 year ago

Basilea initiates clinical phase 3 study with antifungal fosmanogepix in candidemia and invasive candidiasis

Allschwil, Switzerland, September 24, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs…

1 year ago